オリゴヌクレオチド合成の世界市場...市場調査レポートについてご紹介

1 Introduction (Page No. – 20)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 24)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Key Industry Insights
2.4 Assumptions for the Study

3 Executive Summary (Page No. – 33)

4 Premium Insights (Page No. – 38)
4.1 Oligonucleotide Synthesis Market Overview
4.2 Market, By Products & Services
4.3 Market, By Application
4.4 Market, By End User
4.5 Geographic Snapshot of the Market

5 Market Overview (Page No. – 42)
5.1 Introduction
5.2 Market Segmentation
5.2.1 By Products & Services
5.2.2 By Application
5.2.3 By End User
5.2.4 By Region
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Increasing R&D Expenditure in Pharmaceutical & Biotechnology Companies
5.3.1.2 Growing Field of Molecular Diagnostics
5.3.1.3 Increasing Government Investments to Develop Genomic Technologies
5.3.1.4 Rise in Venture Capital Investments
5.3.1.5 Increasing Demand for Synthetic Genes
5.3.2 Restraints
5.3.2.1 Price Erosion of Synthesized Oligos
5.3.2.2 Lack of Regulations for Therapeutic Oligos
5.3.3 Opportunities
5.3.3.1 Emerging Asian Markets
5.3.3.2 Developing Field of Next-Generation Sequencing
5.3.4 Challenges
5.3.4.1 Localization of Business
5.3.4.2 Large-Scale Synthesis of Oligonucleotides

6 Industry Insights (Page No. – 52)
6.1 Introduction
6.1.1 Industry Trends
6.2 Porter’s Five Forces Analysis
6.2.1 Threat From New Entrants
6.2.2 Threat From Substitutes
6.2.3 Bargaining Power of Suppliers
6.2.4 Bargaining Power of Buyers
6.2.5 Intensity of Competitive Rivalry
6.3 Supply Chain Analysis
6.3.1 Key Influencers

7 Oligonucleotide Synthesis Market, By Products & Services (Page No. – 57)
7.1 Introduction
7.2 Synthesized Oligonucleotides
7.2.1 Synthesized Oligonucleotides Market, By Product
7.2.1.1 Primers
7.2.1.2 Probes
7.2.1.3 Large-Scale Synthesis Oligos
7.2.1.4 Intermediate-Scale Synthesis Oligonucleotides
7.2.2 Synthesized Oligonucleotides Market, By Service
7.2.2.1 Custom Oligonucleotides
7.2.2.2 Pre-Designed Oligonucleotides
7.2.3 Reagents
7.2.4 Equipment

8 Oligonucleotide Synthesis Market, By Application (Page No. – 78)
8.1 Introduction
8.2 Research
8.2.1 PCR
8.2.2 Qpcr
8.2.3 Sequencing
8.2.4 Gene Synthesis
8.2.5 Other Research Applications
8.3 Diagnostics
8.4 Therapeutics
8.4.1 DNA/Antisense Oligos
8.4.2 Rnai
8.4.3 Nucleic Acid Aptamers
8.4.4 Other Therapeutic Applications

9 Oligonucleotide Synthesis Market, By End User (Page No. – 105)
9.1 Introduction
9.2 Academic Research Institutes
9.3 Diagnostic Laboratories
9.4 Pharmaceutical and Biotechnology Companies
9.5 Other End Users

10 Regional Analysis (Page No. – 116)
10.1 Introduction
10.2 Pest Analysis
10.2.1 Political Factors
10.2.2 Economic Factors
10.2.3 Social Factors
10.2.4 Technological Factors
10.3 North America
10.3.1 U.S.
10.3.2 Canada
10.4 Europe
10.4.1 Germany
10.4.2 France
10.4.3 U.K.
10.4.4 Rest of Europe (RoE)
10.5 Asia-Pacific (APAC)
10.6 Latin America (Latam)
10.7 Middle East and Africa (MEA)

11 Competitive Landscape (Page No. – 164)
11.1 Overview
11.2 Market Share Analysis
11.3 Competitive Situation and Trends
11.3.1 New Product Launches
11.3.2 Partnerships, Agreements, Contracts, and Collaborations
11.3.3 Expansions
11.3.4 Acquisitions

12 Company Profile (Page No. – 172)
12.1 Introduction
12.2 Integrated DNA Technologies, Inc. (IDT)
12.3 Sigma-Aldrich Corporation
12.4 Eurofins Genomics
12.5 Thermo Fisher Scientific, Inc.
12.6 Bioautomation Corporation
12.7 Agilent Technologies, Inc.
12.8 Biosearch Technologies, Inc.
12.9 Eurogentec S.A.
12.10 General Electric Company (GE)
12.11 Gen9, Inc.
12.12 Genedesign, Inc.
12.13 Genscript Usa Inc.
12.14 Nitto Denko Avecia Inc. (Avecia)
12.15 Trilink Biotechnologies, Inc.

*Details on Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 215)
13.1 Insights From Industry Experts
13.2 Discussion Guide
13.3 Other Developments, By Company, 2012-2015
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports